Ercros (ECR)

Currency in EUR
3.390
-0.010(-0.29%)
Closed·
Earnings results expected in 12 days
ECR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.3903.400
52 wk Range
2.2303.475
Key Statistics
Bid/Ask
3.24 / 3.41
Prev. Close
3.39
Open
3.4
Day's Range
3.39-3.4
52 wk Range
2.23-3.475
Volume
7.43K
Average Volume (3m)
202.01K
1-Year Change
13%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ECR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Ercros News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Feb 27, 2026
EPS / Forecast
-0.14 / --
Revenue / Forecast
170.61M / --
EPS Revisions
Last 90 days

ECR Income Statement

Compare ECR to Peers and Sector

Metrics to compare
ECR
Peers
Sector
Relationship
P/E Ratio
−5.8x−2.5x2.9x
PEG Ratio
0.020.100.00
Price/Book
1.1x1.0x1.6x
Price / LTM Sales
0.5x0.5x1.4x
Upside (Analyst Target)
-22.1%25.6%
Fair Value Upside
Unlock18.1%−2.2%Unlock

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride. It also provides dipentaerythritol, ercrosgreen + resins, formaldehyde, methanol, moulding compounds, paraformaldehyde, pentaerythritol, and sodium formate. In addition, the company offers generic active pharmaceutical ingredients, including amlodipine besylate, azithromycin, clarithromycin, erythromycin, famotidine, fosfomycin, and fusidic acid, as well as customized production of antibiotics, anti-hypertensives, and anti-ulcer drugs. It exports its products. The company was formerly known as S.A. Cros and changed its name to Ercros, S.A. in June 1989. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Industry
Chemicals
Employees
1329
Market
Spain

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
12.75M13.95%43.36M
Other Institutional Investors
73.05M79.89%248.36M
Public Companies & Retail Investors
5.64M6.17%19.17M
Total
91.44M100.00%310.88M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
José de Mello, SGPS, SA77.23%70,615,637240,093
ODDO BHF Asset Management SAS4.90%4,480,00015,232

People Also Watch

21.790
REP
-0.46%
3.4060
SABE
+2.41%
16.510
ENAG
-2.19%
10.5800
SAN
-0.08%
24.190
SLRS
+0.62%

FAQ

What Is the Ercros (ECR) Stock Price Today?

The Ercros stock price today is 3.390 EUR.

What Stock Exchange Does Ercros Trade On?

Ercros is listed and trades on the Madrid Stock Exchange.

What Is the Stock Symbol for Ercros?

The stock symbol for Ercros is "ECR."

What Is the Ercros Market Cap?

As of today, Ercros market cap is 309.970M EUR.

What Is Ercros's Earnings Per Share (TTM)?

The Ercros EPS (TTM) is -0.586.

When Is the Next Ercros Earnings Date?

Ercros will release its next earnings report on May 20, 2026.

From a Technical Analysis Perspective, Is ECR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Ercros Stock Split?

Ercros has split 4 times.

How Many Employees Does Ercros Have?

Ercros has 1329 employees.

What is the current trading status of Ercros (ECR)?

As of May 08, 2026, Ercros (ECR) is trading at a price of 3.390 EUR, with a previous close of 3.390 EUR. The stock has fluctuated within a day range of 3.390 EUR to 3.400 EUR, while its 52-week range spans from 2.230 EUR to 3.475 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.